Metabolomics-Based Clinical Efficacy and Effect on the Endogenous Metabolites of Tangzhiqing Tablet, a Chinese Patent Medicine for Type 2 Diabetes Mellitus with Hypertriglyceridemia

Figure 5

The relationship between insulin resistance and 17 potential biomarkers. Red represented the biomarkers whose peak intensity rose in case group, and green represented the biomarkers whose peak intensity reduced in case group (CK, choline kinase; CT, CTP phosphocholine cytidylyltransferase; CPT, CDP-choline:1,2-diacylglycerol cholinephos-photransferase; lp-PLA2: phospholipase A2; EK, Ethanolamine kinase; ET, phosphoethanolamine cytidylyltransferase; EPT, CDP-ethanolamine:1,2-diacylglycerol ethanolaminephosphotransferase; PEMT, phosphatidylethanolamine N-methyltransferase; SAH, S-adenosylhomocysteine; SAMe, S-adenosylmethionine).